International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 16 , ISSUE S1 ( August, 2023 ) > List of Articles

ORIGINAL RESEARCH

Effect of 38% Silver Diamine Fluoride on Salivary Matrix Metalloproteinase-9 Levels in Children with Early Childhood Caries: A Clinical Study

Prasurjya Bora, Aditya Saxena

Keywords : Early childhood caries, Matrix metalloproteinases, Silver diamine fluoride

Citation Information :

DOI: 10.5005/jp-journals-10005-2618

License: CC BY-NC 4.0

Published Online: 29-08-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Background: Early childhood caries is a major oral health problem in most industrialized countries, affecting the overall quality of life of children. It is caused by the action of bacterial acids on the enamel surface thereby demineralizing it and progressively destroying the tooth. It presents initially as smooth-surface carious lesions affecting the primary maxillary incisors. With the advancement of the lesion, decay progresses further to involve other primary teeth as well and if not treated early, the caries may involve the pulp leading to irreversible pulpitis. Matrix metalloproteinases (MMPs) are a group of endopeptidases that degrade almost all the proteins of the extracellular matrix (ECM). Among the different types of MMP, MMP-9 (gelatinase B) is one of the chief MMPs responsible for the breakdown of the organic matrix. Traces of MMP-9 can be found in the human carious lesions, saliva, and gingival crevicular fluid. They are activated by the release of acids by cariogenic bacteria and once activated they are able to digest demineralized dentin matrix. Thus, host-derived MMPs, which are activated by bacterial acids have a crucial role in the destruction of dentine by caries. Thus, this study was undertaken to investigate the effect of 38% silver diamine fluoride (SDF) solution on MMP-9 levels. Aim: This clinical trial investigated the MMP-9 levels before and after the application of 38% SDF in children with early childhood caries. Materials and methods: About 15 children were selected and were subjected to clinical and radiographic assessment before the commencement of the procedure. After the collection of saliva, the teeth with carious lesions were isolated and SDF was applied. Saliva samples were again collected after 1, 3, and 6 months postapplication of SDF. The collected saliva samples were then analyzed for their MMP-9 levels using a human salivary enzyme-linked immunosorbent assay (ELISA) kit. Finally, the data obtained were subjected to statistical analysis by repeated measures of analysis of variance (ANOVA). Conclusion: The MMP-9 levels were found to be gradually increasing postapplication of 38% SDF and were significantly higher after 6 months and the highest mean difference in the MMP-9 levels was observed between baseline and 6th-month follow-up. Also, no new carious lesion appeared in the teeth during the experimental time period of 6 months and the decayed, extraction needed, filled teeth (deft) scores remained the same.


HTML PDF Share
  1. Chaussain-Miller C, Fioretti F, Goldberg M, et al. The role of matrix metalloproteinases (MMPs) in human caries. J Dent Res 2006;85(1):22–32. DOI: 10.1177/154405910608500104
  2. Tjäderhane L, Larjava H, Sorsa T, et al. The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res 1998;77(8):1622–1629. DOI: 10.1177/00220345980770081001
  3. Mount GJ, Ngo H. Minimal intervention: a new concept for operative dentistry. Quintessence Int 2000;31(8):527–533.
  4. Nelson T, Scott JM, Crystal YO, et al. Silver diamine fluoride in pediatric dentistry training programs: survey of graduate program directors. Pediatr Dent 2016;38(3):212–217.
  5. Fung MHT, Wong MCM, Lo ECM, et al. Arresting early childhood caries with silver diamine fluoride-a literature review. J Oral Hyg Health 2013;1(3):1000117.
  6. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463–516. DOI: 10.1146/annurev.cellbio.17.1.463
  7. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5(8):2145–2154.
  8. Gusman H, Santana RB, Zehnder M. Matrix metalloproteinase levels and gelatinolytic activity in clinically healthy and inflamed human dental pulps. Eur J Oral Sci 2002;110(5):353–357. DOI: 10.1034/j.1600-0722.2002.21347.x
  9. Fung MHT, Duangthip D, Wong MCM, et al. Arresting dentine caries with different concentration and periodicity of silver diamine fluoride. JDR Clin Trans Res 2016;1(2):143–152. DOI: 10.1177/2380084416649150
  10. Mei ML, Ito L, Cao Y, et al. Inhibitory effect of silver diamine fluoride on dentine demineralisation and collagen degradation. J Dent 2013;41(9):809–817. DOI: 10.1016/j.jdent.2013.06.009
  11. Wakshlak RB, Pedahzur R, Avnir D. Antibacterial activity of silver-killed bacteria: the” zombies” effect. Sci Rep 2015;5:9555. DOI: 10.1038/srep09555
  12. Gotjamanos T. Safety issues related to the use of silver fluoride in paediatric dentistry. Aust Dent J 1997;42(3):166–168. DOI: 10.1111/j.1834-7819.1997.tb00115.x
  13. Sulkala M, Wahlgren J, Larmas M, et al. The effects of MMP inhibitors on human salivary MMP activity and caries progression in rats. J Dent Res 2001;80(6):1545–1549. DOI: 10.1177/00220345010800061301
  14. Mei ML, Li QL, Chu CH, et al. The inhibitory effects of silver diamine fluoride at different concentrations on matrix metalloproteinases. Dent Mater 2012;28(8):903–908. DOI: 10.1016/j.dental.2012.04.011
  15. Llodra JC, Rodriguez A, Ferrer B, et al. Efficacy of silver diamine fluoride for caries reduction in primary teeth and first permanent molars of schoolchildren: 36-month clinical trial. J Dent Res 2005;84(8):721–724. DOI: 10.1177/154405910508400807
  16. Oliveira BH, Rajendra A, Veitz-Keenan A, et al. The effect of silver diamine fluoride in preventing caries in the primary dentition: a systematic review and meta-analysis. Caries Res 2019;53(1):24–32. DOI: 10.1159/000488686
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.